vs
Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -127.8%, a 133.3% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ECG vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.1B |
| Net Profit | $55.3M | $-1.4B |
| Gross Margin | 11.6% | 32.6% |
| Operating Margin | 6.8% | -116.0% |
| Net Margin | 5.5% | -127.8% |
| Revenue YoY | 33.2% | -2.5% |
| Net Profit YoY | 60.4% | -3093.9% |
| EPS (diluted) | $1.09 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $986.8M | $1.0B | ||
| Q2 25 | $921.5M | $1.1B | ||
| Q1 25 | $826.6M | $1.0B | ||
| Q4 24 | $759.6M | $1.1B | ||
| Q3 24 | $761.0M | $1.1B | ||
| Q2 24 | $703.4M | $1.1B | ||
| Q1 24 | $625.7M | $1.1B |
| Q4 25 | $55.3M | $-1.4B | ||
| Q3 25 | $57.0M | $7.5M | ||
| Q2 25 | $52.8M | $-8.4M | ||
| Q1 25 | $36.7M | $-6.4M | ||
| Q4 24 | $34.5M | $-44.4M | ||
| Q3 24 | $41.8M | $-21.0M | ||
| Q2 24 | $39.0M | $-108.4M | ||
| Q1 24 | $28.2M | $2.0M |
| Q4 25 | 11.6% | 32.6% | ||
| Q3 25 | 12.6% | 36.1% | ||
| Q2 25 | 13.0% | 34.4% | ||
| Q1 25 | 11.2% | 37.6% | ||
| Q4 24 | 11.4% | 33.9% | ||
| Q3 24 | 11.8% | 37.2% | ||
| Q2 24 | 12.6% | 37.0% | ||
| Q1 24 | 11.9% | 33.1% |
| Q4 25 | 6.8% | -116.0% | ||
| Q3 25 | 7.3% | 7.0% | ||
| Q2 25 | 7.9% | 4.3% | ||
| Q1 25 | 6.2% | 4.5% | ||
| Q4 24 | 6.1% | 10.0% | ||
| Q3 24 | 7.1% | 7.4% | ||
| Q2 24 | 7.3% | -2.5% | ||
| Q1 24 | 6.2% | -5.1% |
| Q4 25 | 5.5% | -127.8% | ||
| Q3 25 | 5.8% | 0.7% | ||
| Q2 25 | 5.7% | -0.8% | ||
| Q1 25 | 4.4% | -0.6% | ||
| Q4 24 | 4.5% | -3.9% | ||
| Q3 24 | 5.5% | -1.9% | ||
| Q2 24 | 5.5% | -10.2% | ||
| Q1 24 | 4.5% | 0.2% |
| Q4 25 | $1.09 | $-10.23 | ||
| Q3 25 | $1.11 | $0.05 | ||
| Q2 25 | $1.03 | $-0.06 | ||
| Q1 25 | $0.72 | $-0.05 | ||
| Q4 24 | $0.68 | $-0.32 | ||
| Q3 24 | $0.82 | $-0.15 | ||
| Q2 24 | $0.76 | $-0.79 | ||
| Q1 24 | $0.55 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $281.5M | — |
| Stockholders' EquityBook value | $629.8M | $2.9B |
| Total Assets | $1.7B | $8.5B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | — | $558.8M | ||
| Q3 24 | $553.0K | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | — | $658.5M |
| Q4 25 | $281.5M | — | ||
| Q3 25 | $285.1M | — | ||
| Q2 25 | $288.6M | — | ||
| Q1 25 | $292.1M | — | ||
| Q4 24 | $295.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $629.8M | $2.9B | ||
| Q3 25 | $573.0M | $4.4B | ||
| Q2 25 | $514.4M | $4.5B | ||
| Q1 25 | $460.2M | $4.4B | ||
| Q4 24 | $422.6M | $4.3B | ||
| Q3 24 | $453.3M | $4.6B | ||
| Q2 24 | $490.0M | $4.5B | ||
| Q1 24 | $464.3M | $4.7B |
| Q4 25 | $1.7B | $8.5B | ||
| Q3 25 | $1.6B | $10.1B | ||
| Q2 25 | $1.5B | $10.1B | ||
| Q1 25 | $1.4B | $9.8B | ||
| Q4 24 | $1.3B | $9.6B | ||
| Q3 24 | $1.3B | $11.2B | ||
| Q2 24 | — | $10.4B | ||
| Q1 24 | — | $10.6B |
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.63× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $48.2M | $175.4M |
| Free Cash FlowOCF − Capex | $23.5M | $148.6M |
| FCF MarginFCF / Revenue | 2.3% | 13.4% |
| Capex IntensityCapex / Revenue | 2.4% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $90.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.2M | $175.4M | ||
| Q3 25 | $76.2M | $51.7M | ||
| Q2 25 | $25.3M | $75.9M | ||
| Q1 25 | $7.1M | $-64.5M | ||
| Q4 24 | — | $312.6M | ||
| Q3 24 | $78.9M | $42.2M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | $21.9M | $-1.4M |
| Q4 25 | $23.5M | $148.6M | ||
| Q3 25 | $65.7M | $29.8M | ||
| Q2 25 | $12.3M | $56.7M | ||
| Q1 25 | $-11.4M | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | $60.9M | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | $12.6M | $-26.5M |
| Q4 25 | 2.3% | 13.4% | ||
| Q3 25 | 6.7% | 2.9% | ||
| Q2 25 | 1.3% | 5.4% | ||
| Q1 25 | -1.4% | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | 8.0% | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | 2.0% | -2.4% |
| Q4 25 | 2.4% | 2.4% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 1.4% | 1.8% | ||
| Q1 25 | 2.2% | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 2.4% | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | 1.5% | 2.3% |
| Q4 25 | 0.87× | — | ||
| Q3 25 | 1.34× | 6.89× | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.77× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
